Accumulating evidence suggests that subjective cognitive complaints (SCC) may indicate subtle cognitive decline characteristic of individuals with preclinical Alzheimer's disease (AD). In this study, we sought to build upon previous studies by associating SCC and amyloid-b deposition using positron emission tomography with Pittsburgh Compound B (PiB-PET) in cognitively normal older individuals. One-hundred thirty one subjects (mean age 73.5 7 6) were administered three subjective cognitive questionnaires and a brief neuropsychological battery. A relationship between a subjective memory complaints composite score and cortical PiB binding was found to be significant, even after controlling for depressive symptoms. By contrast, there were no significant relationships between objective cognitive measures of memory and executive functions and cortical PiB binding. Our study suggests that SCC may be an early indicator of AD pathology detectable prior to significant objective impairment.
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Introduction
As the field positions itself for forthcoming secondary prevention trials, the discovery of sensitive indicators of preclinical Alzheimer's disease (AD) is at a premium. Increasingly, it has been suggested that subjective cognitive complaints (SCC), at the stage of preclinical AD, may indicate initial cognitive decrements that are otherwise undetectable with standardized objective tests of cognitive performance (Reisberg et al., 2008) . The importance of SCC as a diagnostic criterion has already been recognized in MCI (Albert et al., 2011; Petersen et al., 1999) , though evidence suggests that self-reported concerns become less reliable as patients progress towards dementia, whereas informant-report and objective cognitive measures become more accurate (Roberts, Clare, & Woods, 2009 ). Thus, there may be an optimal timeframe in which SCC contribute to our ability to identify individuals atrisk for cognitive decline and eventual AD dementia, but the role of SCC in the early detection of AD remains to be fully elucidated.
Several previous population-based studies have not found associations between SCC and objective cognitive testing in non-demented individuals, raising the possibility that individuals with SCC represent the ''worried well,'' rather than an at-risk group (Bassett & Folstein, 1993; Gagnon et al., 1994) . In fact, it is well-established that SCC relate more strongly to depressive symptomatology and personality traits than objective cognitive impairment (Comijs, Deeg, Dik, Twisk, & Jonker, 2002; Minett, Da Silva, Ortiz, & Bertolucci, 2008; Smith, Petersen, Ivnik, Malec, & Tangalos, 1996) . However, several studies, including our previous work, have considered the effects of depression and have still found a relationship between SCC and objective cognitive functioning in individuals who were non-demented (Amariglio, Townsend, Grodstein, Sperling, & Rentz, 2011; Lam, Lui, Tam, & Chiu, 2005; Snitz, Morrow, Rodriguez, Huber, & Saxton, 2008) .
Longitudinal studies that have used SCC as a predictor of future cognitive decline in Cognitively Normal (CN) individuals have also been mixed. For example, no relationship was found between SCC and cognitive decline after two years in a large community dwelling sample (Jorm et al., 1997) , but a relationship in the same sample was revealed after the third year of follow-up (Jorm, Christensen, Korten, Jacomb, & Henderson, 2001 ). Additionally, several other studies were unable to find relationships between SCC and decline on objective cognitive measures, though longitudinal follow-up and sample size were limited (Flicker, Ferris, & Reisberg, 1993; Taylor, Miller, & Tinklenberg, 1992) . By contrast, others have found that SCC predict future cognitive decline (Dik et al., 2001; Geerlings et al., 1999; Hohman, BeasonHeld, Lamar, & Resnick, 2011; Schmand, Jonker, Hooijer, & 
